Cary Street Partners Investment Advisory’s Rentokil RTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-588
Closed -$21.8K 1576
2023
Q3
$21.8K Buy
+588
New +$22.5K ﹤0.01% 1091
2023
Q1
Sell
-87
Closed -$2.68K 1717
2022
Q4
$2.68K Buy
+87
New +$2.7K ﹤0.01% 1458

Other funds holding RTO

Cary Street Partners Investment Advisory's RTO Position: Q4 2023 in Review

Cary Street Partners Investment Advisory sold out of Rentokil (RTO) in Q4 2023, closing a stake of 588 shares — an estimated $21.8K sold.

Cary Street Partners Investment Advisory first reported a position in RTO in Q4 2022 and held it in 2 quarters. The position peaked at $21.8K in Q3 2023. 189 funds tracked by Wall St. Rank hold RTO as of Q4 2023.

  • Cary Street Partners Investment Advisory reported no remaining Rentokil position as of Q4 2023 after selling out during the quarter.
  • Cary Street Partners Investment Advisory sold 588 Rentokil shares in Q4 2023, an estimated $21.8K.
  • Cary Street Partners Investment Advisory first reported a position in Rentokil in Q4 2022 and held it in 2 quarters.
  • Cary Street Partners Investment Advisory's Rentokil position peaked at $21.8K in Q3 2023.
  • 189 funds tracked by Wall St. Rank held Rentokil as of Q4 2023.

Based on Cary Street Partners Investment Advisory's 13F filing for Q4 2023, filed 5 Feb 2024.